A pragmatic approach to estimating average treatment effects from EHR data The effect of prone positioning on mechanically ventilated COVID-19 patients

Open Access
Authors
Publication date 14-09-2021
Edition v1
Number of pages 28
Organisations
  • Interfacultary Research - Institute for Logic, Language and Computation (ILLC)
Abstract
Despite the recent progress in the field of causal inference, to date there is no agreed upon methodology to glean treatment effect estimation from observational data. The consequence on clinical practice is that, when lacking results from a randomized trial, medical personnel is left without guidance on what seems to be effective in a real-world scenario. This article showcases a pragmatic methodology to obtain preliminary estimation of treatment effect from observational studies. Our approach was tested on the estimation of treatment effect of the proning maneuver on oxygenation levels, on a cohort of COVID-19 Intensive Care patients. We modeled our study design on a recent RCT for proning (the PROSEVA trial). Linear regression, propensity score models such as blocking and DR-IPW, BART and two versions of Counterfactual Regression were employed to provide estimates on observational data comprising first wave COVID-19 ICU patient data from 25 Dutch hospitals. 6371 data points, from 745 mechanically ventilated patients, were included in the study. Estimates for the early effect of proning— P/F ratio from 2 to 8 hours after proning—ranged between 14.54 and 20.11 mm Hg depending on the model. Estimates for the late effect of proning—oxygenation from 12 to 24 hours after proning—ranged between 13.53 and 15.26 mm Hg. All confidence interval being strictly above zero indicated that the effect of proning on oxygenation for COVID-19 patient was positive and comparable in magnitude to the effect on non COVID-19 patients. These results provide further evidence on the effectiveness of proning on the treatment of COVID-19 patients. This study, along with the accompanying open-source code, provides a blueprint for treatment effect estimation in scenarios where RCT data is lacking.
Document type Preprint
Note Version v2 (2021) also available on ArXiv.
Language English
Published at https://doi.org/10.48550/arXiv.2109.06707
Downloads
2109.06707v1 (Submitted manuscript)
2109.06707 (Other version)
Permalink to this page
Back